Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticle-based drug delivery to hair follicles is more effective when tested under conditions that match skin behavior.

Carboxytherapy is a safe and effective treatment for improving skin appearance and treating various skin conditions, with mild side effects.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

Sebaceous glands can heal and regenerate after injury using their own stem cells and help from hair follicle cells.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Hibiscus has medicinal benefits but can be toxic in high doses and is unsafe for pregnant women and infants.

A new gene variant causes glucocorticoid resistance in a mother and son.

Early diagnosis and personalized treatments are crucial for better hair loss management.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Pigmented vellus and upright regrowing hairs predict hair regrowth in severe alopecia.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.